Clinical Trial Update: Glecaprevir/Pibrentasvir for the Treatment of PTSD [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update notes that Phase 2 and Phase 3 studies of the glecaprevir/pibrentasvir combination for post-traumatic stress disorder have completed,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Mavyret (glecaprevir/pibrentasvir)

Snippet

Sponsor: White River Junction Veterans Affairs Medical Center | Conditions: PTSD | Phase 2, Phase 3 | Status: COMPLETED